Published in Biotech Business Week, July 25th, 2005
Negron's appointment to the board brings the number of independent members to six out of a total of 10 directors.
"Negron's substantial achievements in finance and her knowledge of the nutritional and direct selling industries will be extremely beneficial to the company as we look forward to further expanding our business," said Blake Roney, chairman of the board. "Negron enhances our board of directors as a balanced and experienced leader."
Negron is a seasoned financial and business analyst whose...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.